Goyal Associates reports loss for FY26 as revenue falls

1 min read     Updated on 02 Jun 2026, 01:08 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Goyal Associates Limited reported a net loss of ₹2.65 million for the financial year ended March 31, 2026, compared to a net profit of ₹7.55 million in the previous year. Revenue from operations fell to ₹12.95 million from ₹27.46 million, primarily due to a decline in interest income. The board approved the audited financial results on June 1, 2026, with statutory auditors RSRV & Associates issuing an unmodified opinion.

powered bylight_fuzz_icon
41711014

*this image is generated using AI for illustrative purposes only.

Goyal Associates Limited reported a net loss of ₹2.65 million for the financial year ended March 31, 2026, a significant decline from the net profit of ₹7.55 million recorded in the previous year. The company's revenue from operations fell to ₹12.95 million in FY26 from ₹27.46 million in FY25, driven primarily by a decrease in interest on loans and share sales. The board approved the audited financial results for the quarter and year ended March 31, 2026, at a meeting held on June 1, 2026.

The standalone financial results, reviewed by the Audit Committee, were submitted pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. RSRV & Associates, the statutory auditors, issued an unmodified opinion on the results. The company's total assets stood at ₹84.99 million as of March 31, 2026, slightly up from ₹84.77 million in the previous year.

Financial Performance

The company's performance was impacted by a sharp drop in interest income, which fell to ₹0.05 million in FY26 from ₹19.52 million in FY25. Sale of shares contributed ₹12.33 million to revenue in FY26, up from ₹6.74 million in the prior year. Total expenses for the year decreased to ₹15.92 million from ₹18.83 million, with employee benefits expenses and other expenses being the major cost components.

Metric FY26 (₹ Million) FY25 (₹ Million)
Revenue from Operations 12.95 27.46
Total Expenses 15.92 18.83
Net Profit/(Loss) (2.65) 7.55
Earnings Per Share (Basic) (0.05) 0.16

Quarterly Results

For the quarter ended March 31, 2026, the company reported a net loss of ₹3.80 million, compared to a profit of ₹1.47 million in the same quarter of the previous year. Revenue from operations for the quarter stood at ₹4.37 million, down from ₹6.06 million in Q4FY25. The loss was attributed to higher expenses and lower other income during the period.

Balance Sheet Highlights

The balance sheet showed a deterioration in the company's equity, with other equity turning negative at ₹0.54 million compared to a positive ₹2.10 million in the previous year. Cash and cash equivalents decreased significantly to ₹0.26 million from ₹1.44 million, indicating liquidity constraints. Borrowings remained stable at ₹10.52 million.

Historical Stock Returns for Goyal Associates

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-11.76%-20.21%-21.05%-40.00%-80.77%

What strategic measures will the company implement to address the drastic decline in interest income and restore profitability?

How does the company plan to manage its liquidity constraints given the significant drop in cash and cash equivalents?

Will the company seek to refinance or restructure its stable borrowings to improve financial flexibility?

Goyal Associates Limited Appoints Satya Narayana Gogula as Additional Independent Director

1 min read     Updated on 08 Apr 2026, 04:30 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Goyal Associates Limited appointed Satya Narayana Gogula as Additional Independent Director for five years from February 20, 2026, following board approval on the same date. The company later clarified that the board meeting was held from 02:30 p.m. to 03:30 p.m. after inadvertently omitting these details in the original announcement. Mr. Gogula brings over six years of experience in corporate operations, taxation, and business management from organizations including Amazon and Ryanwell India Pharma Pvt. Ltd. The appointment is subject to member approval in the ensuing general meeting and complies with all SEBI regulatory requirements.

powered bylight_fuzz_icon
37191639

*this image is generated using AI for illustrative purposes only.

Goyal Associates Limited has appointed Mr. Satya Narayana Gogula as Additional Independent Director, effective February 20, 2026. The appointment was approved during a board meeting held on the same date and requires member approval in the upcoming general meeting.

Board Meeting Details

The company submitted a clarification to BSE Limited on April 8, 2026, addressing an inadvertent omission in its original corporate announcement. The clarification provided the missing board meeting timings that were required under regulatory compliance.

Meeting Details: Information
Date: February 20, 2026
Commencement Time: 02:30 p.m.
Conclusion Time: 03:30 p.m.

Director Appointment Details

Mr. Gogula's appointment as Additional Non-Executive Independent Director comes with a five-year term starting from February 20, 2026. The company confirmed that he has not been debarred from holding directorial positions by SEBI or any other authority, in compliance with regulatory requirements.

Appointment Parameters: Details
Director Name: Satya Narayana Gogula
DIN: 10209811
Position: Additional Independent Director
Term Duration: 5 consecutive years
Effective Date: February 20, 2026
Relationship to Existing Directors: Not related to any current director

Professional Background

Mr. Gogula brings significant professional experience to the board. He is described as a dynamic professional with diversified experience across corporate operations, taxation, and business management. His career spans over six years in the industry, including positions with notable organizations such as Amazon and Ryanwell India Pharma Pvt. Ltd.

The company highlighted that his experience in business operations and marketing-driven growth environments will strengthen Goyal Associates Limited's strategic focus on:

  • Business development initiatives
  • Market expansion strategies
  • Organizational growth programs

Regulatory Compliance

The appointment was made pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015. The company provided all required disclosures under Regulation 30 of the SEBI (LODR) Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/CFDPoD1/CIR/2023/123 dated July 13, 2023.

The clarification filing demonstrates the company's commitment to maintaining compliance with applicable provisions of SEBI (LODR) Regulations and relevant circulars. The document was digitally signed by Vuppala Naga Malleswara Rao, Chairman and Director of Goyal Associates Limited.

Historical Stock Returns for Goyal Associates

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-11.76%-20.21%-21.05%-40.00%-80.77%

What specific strategic initiatives might Goyal Associates pursue given Mr. Gogula's Amazon and pharma industry experience?

How will the addition of an independent director with marketing expertise impact the company's market expansion plans?

What challenges might arise during the member approval process for this directorial appointment at the upcoming general meeting?

More News on Goyal Associates

1 Year Returns:-40.00%